Beijing Konruns Pharmaceutical Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 455.557 million compared to CNY 348.003 million a year ago. Operating income was CNY 112.379 million compared to CNY 116.883 million a year ago. Net income was CNY 100.022 million compared to CNY 103.056 million a year ago. Basic earnings per share from continuing operations was CNY 0.63 compared to CNY 0.64 a year ago.